Adaptimmune Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

3 Months Ended

Mar. 31, 2019

Note 9 — Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):


	March 31,		December 31,
	2019		2018
Accrued clinical & development expenditure	$	9,432	$	9,637
Accrued employee expenses		4,069		7,553
Accrued rent and property expenses		—		426
Other accrued expenditure		2,027		2,422
Other		299		316
	$	15,827	$	20,354